Shifting the treatment approach for functional GI disorders

Professor Holtmann is Director of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane

OPINION

Functional gastrointestinal disorders (FGIDs) are highly prevalent in the population, with around 34% of Australians suffering from one or more.1

 In recent years we have witnessed a paradigm shift in our understanding of their underlying pathophysiology. FGIDs were previously thought to be unexplained brain-gut disorders with no underlying structural or biochemical basis, so treatments have traditionally targeted the predominant or most troublesome